CCL2 and myelodysplastic syndrome: Interestingly, our investigation into the cytokine profiles of sCD14-PBMC-Sup-treated T cells reveals a distinct secretion pattern that was enriched for pro-inflammatory cytokines like MCP-1, MCP-4, IP-10, MDS, and TARC, suggesting a robust skewing environment.